UC San Diego’s latest study reveals MICAL2 as a critical factor in pancreatic cancer progression, offering new avenues for treatment through targeted therapies that could inhibit this enzyme and slow ...
The researchers have developed and validated neural network models able to differentiate between benign and malignant ovarian lesions, having trained and tested the AI on over 17,000 ultrasound ...